Sangamo Therapeutics Announces Second Quarter 2024 Conference Call and Webcast
Sangamo Therapeutics (Nasdaq: SGMO), a genomic medicine company, has scheduled its second quarter 2024 financial results release for Tuesday, August 6, 2024, after market close. The company will host a conference call at 4:30 p.m. Eastern on the same day to review the results and provide business updates.
Participants can register and access the call using a provided link, with a recommendation to join 10 minutes early. The call will offer options to dial in or use a dial-out feature for instant phone connection. A live webcast will be available on the Sangamo website's Investors and Media section, with a replay accessible afterwards under Events.
Sangamo Therapeutics (Nasdaq: SGMO), un'azienda di medicina genomica, ha programmato il rilascio dei suoi risultati finanziari del secondo trimestre 2024 per martedì 6 agosto 2024, dopo la chiusura del mercato. L'azienda terrà una chiamata in conferenza alle 16:30 ora orientale dello stesso giorno per rivedere i risultati e fornire aggiornamenti aziendali.
I partecipanti possono registrarsi e accedere alla chiamata utilizzando un link fornito, con la raccomandazione di collegarsi con 10 minuti di anticipo. La chiamata offrirà opzioni per telefonare o utilizzare una funzione di richiamata per una connessione telefonica immediata. Sarà disponibile un webcast dal vivo nella sezione Investitori e Media del sito web di Sangamo, con una registrazione accessibile successivamente nella sezione Eventi.
Sangamo Therapeutics (Nasdaq: SGMO), una empresa de medicina genómica, ha programado la publicación de sus resultados financieros del segundo trimestre de 2024 para el martes 6 de agosto de 2024, después del cierre del mercado. La empresa llevará a cabo una conferencia telefónica a las 4:30 p.m. hora del Este del mismo día para revisar los resultados y proporcionar actualizaciones comerciales.
Los participantes pueden registrarse y acceder a la llamada mediante un enlace proporcionado, recomendándose unirse 10 minutos antes. La llamada ofrecerá opciones para marcar o utilizar una función de llamada externa para una conexión telefónica instantánea. Habrá una transmisión en vivo disponible en la sección de Inversores y Medios del sitio web de Sangamo, con una repetición accesible posteriormente en la sección de Eventos.
Sangamo Therapeutics (Nasdaq: SGMO)는 유전자 의학 회사로, 2024년 2분기 재무 결과 발표를 2024년 8월 6일 화요일 시장 마감 후로 예정했습니다. 회사는 같은 날 동부 표준시 오후 4시 30분에 결과 검토 및 사업 업데이트를 위해 콘퍼런스 콜을 진행합니다.
참가자는 제공된 링크를 통해 등록하고 콜에 접근할 수 있으며, 10분 일찍 참여할 것을 권장합니다. 콜은 전화 다이얼 또는 즉각적인 전화 연결을 위한 다이얼 아웃 기능을 제공할 것입니다. Sangamo 웹사이트의 투자자 및 미디어 섹션에서는 실시간 웹캐스트가 제공되며, 이후 이벤트 섹션에서 재방송이 가능합니다.
Sangamo Therapeutics (Nasdaq: SGMO), une entreprise de médecine génomique, a programmé la publication de ses résultats financiers du deuxième trimestre 2024 pour le mardi 6 août 2024, après la fermeture du marché. L'entreprise animera une conférence téléphonique à 16h30, heure de l'Est le même jour pour examiner les résultats et fournir des mises à jour sur les activités.
Les participants peuvent s'inscrire et accéder à l'appel via un lien fourni, avec la recommandation de rejoindre 10 minutes à l'avance. L'appel proposera des options pour se connecter par téléphone ou utiliser une fonction de rappel pour une connexion téléphonique instantanée. Un webinaire en direct sera disponible dans la section Investisseurs et Médias du site Web de Sangamo, avec un replay accessible ultérieurement dans la section Événements.
Sangamo Therapeutics (Nasdaq: SGMO), ein Unternehmen für genetische Medizin, hat die Veröffentlichung seiner Finanzergebnisse für das zweite Quartal 2024 für Dienstag, den 6. August 2024, nach Börsenschluss angesetzt. Das Unternehmen wird am selben Tag um 16:30 Uhr Eastern eine Telefonkonferenz abhalten, um die Ergebnisse zu prüfen und Unternehmensupdates bereitzustellen.
Teilnehmer können sich über einen bereitgestellten Link registrieren und auf den Anruf zugreifen. Es wird empfohlen, 10 Minuten früher einzutreten. Die Konferenz wird Optionen bieten, sich einzuwählen oder eine Rückruffunktion für eine sofortige Telefonverbindung zu nutzen. Ein Live-Webcast wird im Abschnitt Investoren und Medien der Sangamo-Website verfügbar sein, und eine Wiederholung wird später im Bereich Veranstaltungen zugänglich sein.
- None.
- None.
The company will hold a conference call at 4:30 p.m. Eastern on Tuesday, August 6, which will remain open to the public. During the conference call, the company will review its financial results and provide business updates.
Participants should register for, and access, the call using this link. While not required, it is recommended to join 10 minutes prior to the event start. Once registered, participants will be given the option to either dial into the call with the number and unique passcode provided, or to use the dial-out option to connect their phone instantly. The link to access the live webcast can also be found on the Sangamo Therapeutics website in the Investors and Media section under Events.
A replay will be available following the conference call, accessible under Events.
About Sangamo Therapeutics
Sangamo Therapeutics is a genomic medicine company dedicated to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases who do not have adequate or any treatment options. Sangamo’s zinc finger epigenetic regulators are ideally suited to potentially address devastating neurological disorders and Sangamo’s capsid discovery platform is potentially expanding delivery beyond currently available intrathecal delivery capsids, including in the central nervous system. Sangamo’s pipeline also includes multiple partnered programs and programs with opportunities for partnership and investment. To learn more, visit www.sangamo.com and connect with us on LinkedIn and Twitter/X.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240730067228/en/
Investor Relations & Media Inquiries
Louise Wilkie
ir@sangamo.com
media@sangamo.com
Source: Sangamo Therapeutics, Inc.
FAQ
When will Sangamo Therapeutics (SGMO) release its Q2 2024 financial results?
What time is Sangamo Therapeutics' (SGMO) Q2 2024 earnings call scheduled for?
How can investors access Sangamo Therapeutics' (SGMO) Q2 2024 earnings call?
Will there be a webcast of Sangamo Therapeutics' (SGMO) Q2 2024 earnings call?
